Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Atack

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptorsClaire I Dixon, Hannah V Morris, Gerome Breen, et al.
Journal of Medicinal Chemistry|September 16, 2005
A new pyridazine series of GABAA alpha5 ligandsMonique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
Journal of Medicinal Chemistry|March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1Robert W Carling, Kevin W Moore, Leslie J Street, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunitMichael G N Russell, Robert W Carling, John R Atack, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Journal of Medicinal Chemistry|January 6, 2006
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disordersSimon C Goodacre, Leslie J Street, David J Hallett, et al.
Journal of Medicinal Chemistry|April 14, 2006
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyRichard T Lewis, Wesley P Blackaby, Timothy Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding siteLeslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptorsClaire I Dixon, Hannah V Morris, Gerome Breen, et al.
Journal of Medicinal Chemistry|September 16, 2005
A new pyridazine series of GABAA alpha5 ligandsMonique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
Journal of Medicinal Chemistry|March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1Robert W Carling, Kevin W Moore, Leslie J Street, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunitMichael G N Russell, Robert W Carling, John R Atack, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Journal of Medicinal Chemistry|January 6, 2006
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disordersSimon C Goodacre, Leslie J Street, David J Hallett, et al.
Journal of Medicinal Chemistry|April 14, 2006
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyRichard T Lewis, Wesley P Blackaby, Timothy Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding siteLeslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Pageof 10